Annual Pharmacovigilance stakeholders round table meeting at Golf Course hotel
The Annual Pharmacovigilance meeting was held at Golf Course hotel today from 8.00am – 1.00pm and it was on discussing the progress of Pharmacovigilance in the Financial year 2019/2020, challenges faced and the way forward Director Product Safety Miss Helen Ndagije addressing stakeholders Guest of honor Dr. Joseph Mwoga, Program Officer Medicine and Pharmaceutical Policy…
NDA operational research training that took place on 9th to 11th December 2020
Some of the participants at the NDA Operational Research training Awarding of certificates to the participants Dr. Helen Ndagije – Director Product Safety Prof. Joan Kalyango- Facilitating the training Participants at the training Dr. Paul Kutyabami – Facilitating the training Ms. Eseza Mulyagonja – Facilitating the training Dr. Daniel Semakula – Facilitating the training
A glance at NDA performance FY 2019/2020: Product Safety Directorate
Product Safety Directorate is responsible for is responsible for promoting patient safety by monitoring adverse drug events to improve health outcomes.
A glance at NDA performance Financial Year 2019/2020
NDA’s Quality Control Laboratory is prequalified by World Health Organization and, has ISO/IEC 17025:2017 international standard accreditation by ANAB, United States of America. The Laboratory analyzes different categories of medicines, medical devices and public health care products. Inspectorate and Enforcement Directorate ensures that medicines imported into the country are from approved manufacturing sources, and properly…
